ARTICLE | Clinical News
Avastin bevacizumab regulatory update
April 6, 2009 7:00 AM UTC
FDA's Oncologic Drugs Advisory Committee voted 10-0 that the response seen with Avastin bevacizumab from Roche's Genentech Inc. unit in patients with previously treated glioblastoma multiforme (GBM) ...